TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX/GILD

Gilead Sciences CDR (CAD Hedged) (GILD : TSX)

Common Stock

$29.77

CAD

+0.29 (0.98%)

Last updated: 2026-09-16

💰

Dividend Declared

2 days ago

$0.1649 CAD per share dividend. Ex-dividend date: September 15, 2026Payment date: October 7, 2026Upcoming

Get GILD alerts:

GILD

Gilead Sciences CDR (CAD Hedged)

Source:WealthAwesomeWealthAwesome
$3.19 (12.00%)
30 day period
$26.38$28.43$30.48Aug 5Aug 26Sep 16

Performance

1 Day

+0.98%

1 Week

+1.36%

1 Month

+6.06%

YTD

+19.46%

Key Statistics

Market Cap

$174.33B

52W High

$31.24

52W Low

$21.95

P/E Ratio

-

50 Day MA

$28.03

200 Day MA

$27.79

Beta

-

Dividend Yield

10.92%

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/16/2026$29.68$29.95$29.68$29.77$29.773,200
9/15/2026$29.22$29.48$29.16$29.48$29.4819,500
9/14/2026$29.28$29.55$29.16$29.52$29.5213,389
9/11/2026$29.29$29.29$28.98$28.98$28.985,414
9/10/2026$29.22$29.24$29.11$29.20$29.207,351
9/9/2026$29.31$29.49$29.31$29.37$29.3725,374
9/8/2026$29.67$29.74$29.41$29.52$29.5218,938
9/4/2026$30.23$30.42$30.23$30.42$30.424,500
9/3/2026$30.31$30.51$30.19$30.48$30.48887
9/2/2026$30.36$30.36$30.12$30.12$30.129,765

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GILD's historical volatility

HistoricalForecast68%95%
C$23.95C$29.19C$34.44C$39.68C$44.92C$50.17TodayMay 6Jul 14Sep 16Oct 29Dec 12Jan 24

30-Day Vol

26.2%

Annualized

90-Day Vol

29.3%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$35.59

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$31.60C$28.86C$34.59
60 trading daysC$33.53C$29.50C$38.12
90 trading daysC$35.59C$30.42C$41.63

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Gilead Sciences CDR (CAD Hedged)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Financials

Revenue (TTM)
$0
EBITDA
-
Profit Margin
0.00%
ROE (TTM)
4049.30%
EPS (Diluted)
0.00
Book Value
-

Recent Dividends

$0.000$0.084$0.1672025-06-13: $0.16402025-09-15: $0.16332025-12-15: $0.16012026-03-13: $0.16702026-09-15: $0.1649Jun 25Dec 25Sep 26

$0.1649CAD

Ex: Sep 15, 2026

Pay: Oct 7

Quarterly

$0.1670CAD

Ex: Mar 13, 2026

$0.1601CAD

Ex: Dec 15, 2025

$0.1633CAD

Ex: Sep 15, 2025

$0.1640CAD

Ex: Jun 13, 2025

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About GILD

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
GLOGlobal Atomic Corp$0.71+44.90%
DIAMStar Diamond Corp$0.03+25.00%
EGLXEnthusiast Gaming Holdings Inc$0.04+14.29%
YRBYorbeau Resources Inc$0.06+10.00%
COPRCoppernico Metals Inc.$0.44+8.64%
NFGCNew Found Gold Corp.$2.42+7.56%
TELYTelyRx Holdings Inc.$2.25+7.14%
LABSMedipharm Labs Corp$0.07+7.14%

GILD.TO news timeline

1 article covering GILD.TO, most recent first

Latest

Gilead Sciences CDR (CAD Hedged) (GILD.TO) went ex-dividend — CA$0.1649

Investing

Advertisement